• Title/Summary/Keyword: Small Cell

Search Result 4,074, Processing Time 0.033 seconds

Postoperative Radiation Therapy in Resected Stage stage II and IIIA Non-Small Cell Lung Cancer (Yonsei Cancer Center 20-Year Experience) (근치적 절제후 병기 II,IIIA 비소세포암에서 수술후 방사선 치료의 역할 [연세암센터 20년 경험])

  • 이창걸
    • Journal of Chest Surgery
    • /
    • v.26 no.9
    • /
    • pp.686-695
    • /
    • 1993
  • A total of eighty one patients with resected stage II and IIIA non-small cell lung cancer treated with postoperative adjuvant radiation therapy between Jan. 1971 and Dec. 1990 were retrospectively analysed to evaluate whether postoperative radiation therapy improves survival. Patterns of failure and prognostic factors were also analysed. The 5 year overall and disease free survival rate were 40.5%, 43.4% and median survival 30 months. The 5 year actuarial survival rates by stage II and IIIA were 53.9% and 36.2%. Loco-regional failure rate was 14.7% and distant metastasis rate was 33.3% and both 4%. Statistically significant prognostic factor affecting survival was presence of mediastinal lymph node metastasis[N2]. This retrospective study suggests that postoperative radiation therapy in resected stage II and IIIA non-small cell lung cancer can reduce loco-regional recurrence and may improve survival rate as compared with other studies which were treated by surgery alone.

  • PDF

Primary Small Cell Carcinoma of the Urinary Bladder - Mini-review of the Literature

  • Chhabra, Sarabjeet;Hegde, Padmaraj;Singhal, Paras
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.13 no.8
    • /
    • pp.3549-3553
    • /
    • 2012
  • Primary small cell carcinoma of urinary bladder is a rare but aggressive disease with poor prognosis and a high mortality rate. It accounts for less than 1 % of all the primary cancers seen in the urinary bladder. Diagnosis and management of this entity poses a challenge to the clinician due to the lack of a standardized protocol for its treatment. Herein we discuss primary small cell carcinoma of the urinary bladder in its entirety.

A Case of Neuroendocrine Small Cell Carcinoma Arising from the Hypopharynx (하인두에 발생한 신경내분비성 소세포암종 1예)

  • Koh Yoon-Woo;Lee Jong-Dae;Byun Jang-Yul;Lee Jae-Yong
    • Korean Journal of Head & Neck Oncology
    • /
    • v.20 no.2
    • /
    • pp.198-201
    • /
    • 2004
  • Neuroendocrine carcinomas are rare neoplasms of the hypopharynx. Neuroendocrine neoplasms are divided into four main types : carcinoid, atypical carcinoid, small cell carcinoma and paraganglioma. The diagnosis is primarily based on light microscopy and should be confirmed by immunohistochemical investigation. Small cell neuroendocrine carcinoma of the hypopharynx is extremely uncommon tumor and surgical results for this tumor have been disappointing. Chemotherapy and radiotherapy currently appear the most effective forms of therapy. We report our case of small cell neuroendocrine carcinoma of the hypopharynx with the brief review of literatures.

Distributed User Association Based on Message Passing for Energy Efficiency in a Small-Cell Network (스몰-셀 네트워크에서 에너지 효율 향상을 위한 메시지 전달 기반 분산 사용자 연계)

  • Jeong, Hyun Woo;Kim, Yun Hee
    • The Journal of Korean Institute of Communications and Information Sciences
    • /
    • v.40 no.8
    • /
    • pp.1518-1520
    • /
    • 2015
  • This letter considers a problem of associating users to small-cell base stations (sBSs) and selecting a set of operating sBSs in a small-cell network to minimize the power consumption. We derive a message passing algorithm to obtain a solution distributively. Simulation results show that the proposed algorithm is superior to the conventional schemes.

A Case of Immunotherapy in Small Cell Type Malignant Melanoma of Nasal Cavity (비강 내 소세포형 악성 흑색종의 면역치료 1예)

  • Kim, Chang Hoi;Kwon, Jae Hwan;Kim, Ju Yeon
    • Journal of Clinical Otolaryngology Head and Neck Surgery
    • /
    • v.29 no.2
    • /
    • pp.259-263
    • /
    • 2018
  • There are many treatment options for the malignant melanoma. Wide excisional surgery is one of the most acceptable treatments for locoregional treatment. Depending on the pathologic classification, however, some other treatment option can be included such as chemotherapy, radiotherapy and immunotherapy as adjuvant treatment. Small cell type malignant melanoma is a rare variant of malignant melanoma. It is known that melanomas manifesting this morphology are invariably in vertical growth phase and have an aggressive course. The authors encountered small cell type malignant melanoma and would like to share the experience of successful treatment with surgery plus immunotherapy as one of adjuvant treatment options.

A Bankruptcy Game for Optimize Caching Resource Allocation in Small Cell Networks

  • Zhang, Liying;Wang, Gang;Wang, Fuxiang
    • KSII Transactions on Internet and Information Systems (TIIS)
    • /
    • v.13 no.5
    • /
    • pp.2319-2337
    • /
    • 2019
  • In this paper, we study the distributed cooperative caching for Internet content providers in a small cell of heterogeneous network (HetNet). A general framework based on bankruptcy game model is put forth for finding the optimal caching policy. In this framework, the small cell and different content providers are modeled as bankrupt company and players, respectively. By introducing strategic decisions into the bankruptcy game, we propose a caching value assessment algorithm based on analytic hierarchy process in the framework of bankruptcy game theory to optimize the caching strategy and increase cache hit ratio. Our analysis shows that resource utilization can be improved through cooperative sharing while considering content providers' satisfaction. When the cache value is measured by multiple factors, not just popularity, the cache hit rate for user access is also increased. Simulation results show that our approach can improve the cache hit rate while ensuring the fairness of the distribution.

Dynamic Channel Allocation in Closed-Access Small Cell Networks (폐쇄형 접속 방식의 소형셀 네트워크를 위한 동적 채널 할당 알고리즘)

  • Mun, Cheol;Jo, Han-Shin
    • The Journal of Korean Institute of Communications and Information Sciences
    • /
    • v.39A no.1
    • /
    • pp.50-61
    • /
    • 2014
  • Operating small cell with existing macro cell is of interest in wireless communication technology to enhance network capacity. Closed-access small cell allows the access of users registered in it and causes severe interference to nearby users connected to macrocell. We propose a dynamic channel allocation for small cells in the same building that first aim to minimize call-drop of the nearby macrocell users, and then want to reduce interferences between the small cells. Since the interference effect of small cells on the nearby macrocell users mainly depends on the small cells' position, the proposed algorithm includes a self-configuration to flexibly allocate frequency channels according to the variation of downlink quality of the macrocell users. Furthermore the algorithm is very simple and practical, which is main contribution of this paper. We observe that the proposed algorithm provides 82-94% of maximum achievable throughput.

A study on the Application of PB/MC-CDMA for IoT Services in Small Cell Environment (IoT 서비스를 위한 스몰셀 환경에서 PB/MC-CDMA 적용 방안에 대한 연구)

  • Lee, Kyu-Jin
    • Journal of Convergence Society for SMB
    • /
    • v.6 no.3
    • /
    • pp.21-27
    • /
    • 2016
  • In this paper, we introduce the PB/MC-CDMA (Partial Block/Multi-Carrier-Code Division Multiple Access) system to mitigate inter-cell interference (ICI) and enhance user capacity in the small cell environment. In 5G mobile communications, the number of devices connected to the network is expected to increase exponentially with the expansion of the IoT (Internet of Things) services. In addition, each device is expected to be required by the various data rates by their content types. In LTE/LTE-A, there are some limitations that large scale connectivity and supporting various data rates. Therefore, we introduce a PB/MC-CDMA physical layer system which is suitable for the small cell environment, and evaluate the performance in the multi cell environment which is affected by ICI. Through computer simulation results, we demonstrate the effectiveness of PB/MC-CDMA for the small cell environment.

Interference Neutralization for Small-Cell Wireless Networks (스몰셀 무선망 간섭 상쇄 기법 연구)

  • Jeon, Sang-Woon;Jung, Bang Chul
    • The Journal of Korean Institute of Communications and Information Sciences
    • /
    • v.38A no.12
    • /
    • pp.1117-1124
    • /
    • 2013
  • As the recently soaring wireless traffic, small-cell techniques have been actively studied in order to support such a wireless demand for cellular wireless networks. This paper focuses on the inter-cell interference neutralization to resolve the main barrier for implementing small-cell cellular networks. Assuming that each message is delivered to the final destination by the help of base stations or relays, ergodic interference neutralization is proposed, which exploits the time-varying nature of wireless channels. The previous approach based on amplify-and-forward (AF) suffers from severe performance degradation in the low signal-to-noise (SNR) regime due to noise amplification. On the other hand, the proposed interference neutralization based on recently developed compute-and-forward (CF) fixes such a problem and improves the performance in the low SNR regime.

Radiation Therapy in Non-Small Cell LUNG Cancer (비소세포성 폐암의 방사선 치료)

  • Han, Hae-Gyeong;Lee, Myung-Za
    • Radiation Oncology Journal
    • /
    • v.6 no.1
    • /
    • pp.35-39
    • /
    • 1988
  • From Jan.1984 to Dec. 1986, 90 patients with lung cancer were treated at the Department of Radiation Therapy in Hanyang University Hospital. Histopathologically, 67 cases of them were the squamous cell carcinoma,7 cases were the adenocarcinoma, 4 cases were the large cell undiffe rentiated carcinoma and 12 cases were the small cell carcinoma. Among the 78 patients with non small cell carcinoma, 50 patients had received radiation dosage above 4000 cGy.40 patient had follow up from 17 months to 53 months. The complete response rate was $7.3\%$ and partial response rate was $68.3\%$. Overall survival at 1, 2 and 3 years were $47.5\%,\;23.5\%\;and\;6.3\%$ respectively. None was survived longer than 38 months. Median survival was 12.2 month for 40 patient and 9 month for stage III, M1 group and 9.5 month for stage III, MO group. In M1 patient no survival was seen after 2 years while in M0 patient $23.3\%$ survival was seen.

  • PDF